Marc D. Hein

Halomine, Inc.

$810,086

Attributed

$972,586

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $647.6K · FY2023–25

$1M$750K$500K$250K$0

'23

'24

'25

Funding mix

By agency

NIH$972,586 · 3

By mechanism

R43$972,586 · 3

Top collaborators

Ekrem Ozkan1 shared

Most similar at Halomine, Inc.

Same institution · by research overlap

Carine Nkemngong$1,735,315

Others in their field

Other Rising Stars on “Resistance”

Supriya Menezes · The Emmes Company, Llc$18,394,958
Xuping Xie · University Of Texas Med Br Galveston$13,737,799
Heinz Ernst Moser · University Of Texas Med Br Galveston$12,973,432
Chris Maxwell · National Institute Of Allergy And Infectious Diseases$12,000,000
Andrew Tomaras · Forge Therapeutics, Inc.$10,977,909
Christine W Hockett · Avera Mckennan$8,908,366

Research focus

ResistanceMicrobial BiofilmsRecording Of Previous EventsSafetyAntimicrobialIn VivoMonomerPreventGenerationsCostPolymersHydrogelsInfectionHypochlorous AcidAnti-Bacterial AgentsFormulationHydrophilicityIn VitroClinical TrialsCreamChlorineAntimicrobial ResistanceChronicDesign

Grant awards (3)

Novel, bio-inspired chloramine for infection eradication in chronic wounds$348,150

R43 · FY2025 · DK · contact PI

Novel, bio-inspired chloramine to treat cutaneous fungal infections without resistance generation potential$299,435

R43 · FY2025 · AI · contact PI

Non-coating anti-microbial, anti-host protein deposition, anti-inflammatory urinary catheter$325,001

R43 · FY2023 · DK